Business
Cardiff Oncology Inc (NASDAQ: CRDF) Has Slid Negatively For The Year To Date, Predicting What Will Happen Next
Cardiff Oncology Inc (NASDAQ:CRDF)’s traded shares stood at 0.57 million during the latest session, with the company’s beta value hitting 1.73. At the last check
